An interaction domain in human SAMD9 is essential for myxoma virus host-range determinant M062 antagonism of host anti-viral function
-
Add time:08/29/2019 Source:sciencedirect.com
In humans, deleterious mutations in the sterile α motif domain protein 9 (SAMD9) gene are associated with cancer, inflammation, weakening of the immune response, and developmental arrest. However, the biological function of SAMD9 and its sequence-structure relationships remain to be characterized. Previously, we found that an essential host range factor, M062 protein from myxoma virus (MYXV), antagonized the function of human SAMD9. In this study, we examine the interaction between M062 and human SAMD9 to identify regions that are critical to SAMD9 function. We also characterize the in vitro kinetics of the interaction. In an infection assay, exogenous expression of SAMD9 N-terminus leads to a potent inhibition of wild-type MYXV infection. We reason that this effect is due to the sequestration of viral M062 by the exogenously expressed N-terminal SAMD9 region. Our studies reveal the first molecular insight into viral M062-dependent mechanisms that suppress human SAMD9-associated antiviral function.
We also recommend Trading Suppliers and Manufacturers of myxoma virus growth factor (cas 108174-48-7). Pls Click Website Link as below: cas 108174-48-7 suppliers
Prev:Original ArticleMyxoma Virus Optimizes Cisplatin for the Treatment of Ovarian Cancer In Vitro and in a Syngeneic Murine Dissemination Model
Next:Vaccination of cats with an attenuated recombinant myxoma virus expressing feline calicivirus capsid protein) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- ReviewOncolytic Viruses and Immune Checkpoint Inhibition: The Best of Both Worlds08/31/2019
- Vaccination of cats with an attenuated recombinant myxoma virus expressing feline calicivirus capsid protein08/30/2019
- Original ArticleMyxoma Virus Optimizes Cisplatin for the Treatment of Ovarian Cancer In Vitro and in a Syngeneic Murine Dissemination Model08/28/2019
- Original ArticleOncolytic Virus-Mediated RAS Targeting in Rhabdomyosarcoma08/27/2019
- Oncolytic myxoma virus: The path to clinic08/26/2019
- Host-specificity of myxoma virus: Pathogenesis of South American and North American strains of myxoma virus in two North American lagomorph species08/25/2019
- Molecular and serological analysis of the epidemiology of myxoma virus in rabbits08/24/2019
- Review articleExtracardiac manifestations of atrial myxomas08/23/2019
- ReviewThe immunoregulatory properties of oncolytic myxoma virus and their implications in therapeutics08/22/2019


